Gestational Tissue-Derived Human Mesenchymal Stem Cells Use Distinct Combinations of Bioactive Molecules to Suppress the Proliferation of Human Hepatoblastoma and Colorectal Cancer Cells

Gestational Tissue-Derived Human Mesenchymal Stem Cells Use Distinct Combinations of Bioactive Molecules to Suppress the Proliferation of Human Hepatoblastoma and Colorectal Cancer Cells

Background. Cancer has been considered a serious global health problem and a leading cause of morbidity and mortality worldwide. Despite recent advances in cancer therapy, treatments of advance stage cancers are mostly ineffective resulting in poor survival of patients. Recent evidences suggest that...

Full description

Bibliographic Details
Main Authors:	Nitchapon Paiboon, Witchayaporn Kamprom, Sirikul Manochantr, Chairat Tantrawatpan, Duangrat Tantikanlayaporn, Sittiruk Roytrakul, Pakpoom Kheolamai
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2019/9748795

Similar Items

Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord
by: Sermporn Thaweesapphithak, et al.
Published: (2019-03-01)

MicroRNA treatment modulates osteogenic differentiation potential of mesenchymal stem cells derived from human chorion and placenta
by: Kulisara Marupanthorn, et al.
Published: (2021-04-01)

The Effects of High Glucose on Adipogenic and Osteogenic Differentiation of Gestational Tissue-Derived MSCs
by: Weerawan Hankamolsiri, et al.
Published: (2016-01-01)

Andrographolide promotes proliferative and osteogenic potentials of human placenta-derived mesenchymal stem cells through the activation of Wnt/β-catenin signaling
by: Naruphong Phunikom, et al.
Published: (2021-04-01)

The Effects of BMP-2, miR-31, miR-106a, and miR-148a on Osteogenic Differentiation of MSCs Derived from Amnion in Comparison with MSCs Derived from the Bone Marrow
by: Sirikul Manochantr, et al.
Published: (2017-01-01)

Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells
by: Witchayaporn Kamprom, et al.
Published: (2016-01-01)

Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control
by: U-pratya Yaowalak, et al.
Published: (2010-04-01)

Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines
by: Chairoungdua, A., et al.
Published: (2022)

Effect of estradiol and bisphenol A on human hepatoblastoma cell viability and telomerase activity
by: B.L. Xu, et al.
Published: (2015-11-01)

Study of apoptosis and drug resistance in human hepatocellular carcinoma and hepatoblastoma cell lines
by: Cheng, Samuel Chak-Sum
Published: (2006)

A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
by: Sarah E. Woodfield, et al.
Published: (2017-12-01)

Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells
by: Tea Soini, et al.
Published: (2018-08-01)

Downregulation of transcription factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced apoptosis
by: Tea Soini, et al.
Published: (2017-03-01)

Investigation of Huanglian (Rhizoma Coptidis) extract Induced Cell Apoptosis in Human Hepatoblastoma HepG2 Cells
by: PENG,YA-JYUN, et al.
Published: (2018)

Hepatoblastoma
by: Raùl Pichardo-Bahena, et al.
Published: (2005-04-01)

Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma
by: Alexander Bondoc, et al.
Published: (2021-09-01)

Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of Human Hepatoblastoma Cells
by: Lujing Wang, et al.
Published: (2019-09-01)

The effect of knockdown of insulin receptor substrates 1 and 2 on glucose and lipid metabolism in human hepatoblastoma cells
by: Yu Tianfei, et al.
Published: (2018-01-01)

Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
by: Anna Alisi, et al.
Published: (2013-12-01)

Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors
by: Ponthip Potirat, et al.
Published: (2018-10-01)

Genetic variation and phylogenetic relationship of Hypoderaeum conoideum (Bloch, 1782) Dietz, 1909 (Trematoda: Echinostomatidae) inferred from nuclear and mitochondrial DNA sequences
by: Chairat Tantrawatpan, et al.
Published: (2020-01-01)

Adult hepatoblastoma
by: Javier A. Cienfuegos, et al.

Characterizing and restoring urea cycle function in human hepatoblastoma-derived cell lines for use in bioartificial liver devices
by: Mavri-Damelin, Demetra
Published: (2007)

Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma Cells
by: Tan J, et al.
Published: (2020-05-01)

The Mechanism of crude extract of Tetragonia tetragonoides induced cell cycle arrest and apoptosis in human hepatoblastoma Hep G2 cell lines
by: Jiun-Long Yang, et al.
Published: (2006)

Hepatoblastoma survival and the prognostic role of cancer stem cell markers
by: Mohamed Fawzy, et al.
Published: (2014-02-01)

Neuropilin-2 Is Associated With Increased Hepatoblastoma Cell Viability and Motility
by: Katja Eloranta, et al.
Published: (2021-06-01)

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
by: Sascha Venturelli, et al.
Published: (2013-01-01)

Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.
by: Sascha Venturelli, et al.
Published: (2013-01-01)

Efficacy of a Polyurethane Foam/Spheroid Artificial Liver by Using Human Hepatoblastoma Cell Line (Hep G2)
by: J. Fukuda, et al.
Published: (2003-01-01)

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells.
by: Sascha Venturelli, et al.
Published: (2013-01-01)

LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway
by: Jing Li, et al.
Published: (2020-07-01)

Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion
by: Kasima Wasuworawong, et al.
Published: (2015-01-01)

Chloroquine Triggers Cell Death and Inhibits PARPs in Cell Models of Aggressive Hepatoblastoma
by: Katja Eloranta, et al.
Published: (2020-07-01)

Andrographolide modulates OPG/RANKL axis to promote osteoblastic differentiation in MC3T3-E1 cells and protects bone loss during estrogen deficiency in rats
by: Duangrat Tantikanlayaporn, et al.
Published: (2020-11-01)

A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
by: James A. Saltsman, et al.
Published: (2020-09-01)

The Genetic Changes of Hepatoblastoma
by: Huitong Chen, et al.
Published: (2021-07-01)

Hepatoblastoma: when to screen?
by: O’Malley Margaret, et al.
Published: (2011-03-01)

Hepatoblastoma with precocious puberty
by: Enono Yhoshu, et al.
Published: (2019-01-01)

PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
by: Laura L Stafman, et al.
Published: (2019-01-01)